Patents by Inventor Timothy R. Fouts

Timothy R. Fouts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Erosion sensor and system, method, and computer program product thereof
    Patent number: 10215660
    Abstract: Erosion sensors and systems, methods, and computer products thereof are operative to determine and provide real time erosion data. Such data may be used to determine in real time an amount of erosion or ablation on an ablative surface, for instance, of a rocket or missile launch pad, of an exhaust management system, of an extraterrestrial vehicle, or of a fire detection system.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: February 26, 2019
    Assignee: Lockheed Martin Corporation
    Inventors: William Kraft, Leszek S. Basak, Timothy R. Fouts
  • Adaptable launching system
    Patent number: 8397613
    Abstract: A launch system for use as a standalone munition launcher or as a guest launcher within a main battery host launcher.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: March 19, 2013
    Assignee: Lockheed Martin Corporation
    Inventors: Daniel A. Skurdal, Timothy R. Fouts, Jennifer L. Houston-Manchester, John Snediker
  • Virus coat protein/receptor chimeras and methods of use
    Patent number: 8183354
    Abstract: The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occn-panty of co-receptor present on the cell, for example. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CCR5 and CXCR4 sequences.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: May 22, 2012
    Assignee: University of Maryland, Baltimore
    Inventors: Anthony L. DeVico, Timothy R. Fouts, Robert G. Tuskan
  • Adaptable Launching System
    Publication number: 20090126556
    Abstract: A launch system for use as a standalone munition launcher or as a guest launcher within a main battery host launcher.
    Type: Application
    Filed: November 20, 2008
    Publication date: May 21, 2009
    Applicant: LOCKHEED MARTIN CORPORATION
    Inventors: Daniel A. Skurdal, Timothy R. Fouts, Jennifer L. Houston-Manchester, John Snediker
  • VIRUS COAT PROTEIN/RECEPTOR CHIMERAS AND METHODS OF USE
    Publication number: 20090081124
    Abstract: The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occn-panty of co-receptor present on the cell, for example. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CCR5 and CXCR4 sequences.
    Type: Application
    Filed: November 15, 2007
    Publication date: March 26, 2009
    Inventors: Anthony Louis DeVico, Timothy R. Fouts, Robert G. Tuskan
  • Virus coat protein/receptor chimeras and method of use
    Patent number: 7399473
    Abstract: The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of a co-receptor present on the cell. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CD4 D1D2 and CD4M9 sequences.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: July 15, 2008
    Assignee: University of Maryland Biotechnology Institute
    Inventors: Anthony Louis Devico, Timothy R. Fouts, Robert G. Tuskan
  • Virus coat protein/receptor chimeras and methods of use
    Patent number: 7311920
    Abstract: The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can interact with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of co-receptor present on the cell, for example. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CCR5 and CXCR4 sequences.
    Type: Grant
    Filed: October 6, 2000
    Date of Patent: December 25, 2007
    Assignee: University of Maryland Biotechnology Institute
    Inventors: Anthony Louis Devico, Timothy R. Fouts, Robert G. Tuskan
  • Virus coat protein/receptor chimeras and methods of use
    Patent number: 6908612
    Abstract: The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of a co-receptor present on the cell. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CD4 D1D2 and CD4M9 sequences.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: June 21, 2005
    Assignee: University of Maryland Biotechnology Institute
    Inventors: Anthony Louis Devico, Timothy R. Fouts, Robert G. Tuskan
  • Virus coat protein/receptor chimeras and methods of use
    Publication number: 20020155121
    Abstract: The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of a co-receptor present on the cell. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CD4 D1D2 and CD4M9 sequences.
    Type: Application
    Filed: August 21, 2001
    Publication date: October 24, 2002
    Inventors: Anthony Louis Devico, Timothy R. Fouts, Robert G. Tuskan